SYK logo

Stryker Corporation Stock Price

NYSE:SYK Community·US$139.3b Market Cap
  • 2 Narratives written by author
  • 0 Comments on narratives written by author
  • 91 Fair Values set on narratives written by author

SYK Share Price Performance

US$360.48
-29.66 (-7.60%)
US$433.19
Fair Value
US$360.48
-29.66 (-7.60%)
16.6% undervalued intrinsic discount
US$432.09
Fair Value
Price US$360.48
AnalystConsensusTarget US$432.09
Tokyo US$323.52

SYK Community Narratives

AnalystConsensusTarget·
Fair Value US$433.19 16.8% undervalued intrinsic discount

Aging Populations And Emerging Markets Will Transform Healthcare

0users have liked this narrative
0users have commented on this narrative
41users have followed this narrative
Tokyo·
Fair Value US$323.52 11.4% overvalued intrinsic discount

Investing in Stryker (SYK) should be an easy ride

1users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
US$323.52
11.4% overvalued intrinsic discount
Tokyo Fair Value
Revenue growth
6% p.a.
Profit Margin
16.03%
Future PE
37.32x
Share price in 2029
US$432.95
US$433.19
16.8% undervalued intrinsic discount
Revenue growth
8.44% p.a.
Profit Margin
17.68%
Future PE
38.73x
Share price in 2028
US$539.45

Updated Narratives

SYK logo

Investing in Stryker (SYK) should be an easy ride

Fair Value: US$323.52 11.4% overvalued intrinsic discount
5 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
SYK logo

Aging Populations And Emerging Markets Will Transform Healthcare

Fair Value: US$433.19 16.8% undervalued intrinsic discount
41 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Adequate balance sheet average dividend payer.

3 Risks
1 Reward

Stryker Corporation Key Details

US$24.4b

Revenue

US$8.5b

Cost of Revenue

US$15.9b

Gross Profit

US$12.9b

Other Expenses

US$2.9b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
7.70
65.05%
12.07%
76.2%
View Full Analysis

About SYK

Founded
1941
Employees
53000
CEO
Kevin Lobo
WebsiteView website
www.stryker.com

Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke, cranial, and maxillofacial and chest wall devices, as well as dural substitutes and sealants; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries; thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Recent SYK News & Updates

Recent updates

No updates